Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo

La pandemia por COVID-19 ha supuesto el advenimiento de una serie de retos para los clínicos entre los que se ha descrito desde la presentación de los primeros casos la asociación entre la neumonía viral con los fenómenos embólicos. Por esta razón se describió la prevalencia de eventos embólicos en...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2023
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
spa
OAI Identifier:
oai:repository.urosario.edu.co:10336/39842
Acceso en línea:
https://doi.org/10.48713/10336_39842
https://repository.urosario.edu.co/handle/10336/39842
Palabra clave:
COVID-19
Enfermedad por Coronavirus 2019-nCoV
Tromboembolia Venosa
Embolia Pulmonar
COVID-19
Coronavirus Disease 2019-nCoV
Venous Thromboembolism
Pulmonary Embolism
Rights
License
Attribution-NonCommercial-ShareAlike 4.0 International
id EDOCUR2_2f20f4cfea8786d33737d11855d62c78
oai_identifier_str oai:repository.urosario.edu.co:10336/39842
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.none.fl_str_mv Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
dc.title.TranslatedTitle.none.fl_str_mv Embolic complications in patients infected by SARS-COV-2. Cardioinfantil Foundation. 2020. A retrospective prevalence study
title Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
spellingShingle Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
COVID-19
Enfermedad por Coronavirus 2019-nCoV
Tromboembolia Venosa
Embolia Pulmonar
COVID-19
Coronavirus Disease 2019-nCoV
Venous Thromboembolism
Pulmonary Embolism
title_short Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
title_full Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
title_fullStr Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
title_full_unstemmed Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
title_sort Complicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivo
dc.contributor.advisor.none.fl_str_mv Moreno León, Julián Mauricio
Molano González, Nicolas
dc.subject.none.fl_str_mv COVID-19
Enfermedad por Coronavirus 2019-nCoV
Tromboembolia Venosa
Embolia Pulmonar
topic COVID-19
Enfermedad por Coronavirus 2019-nCoV
Tromboembolia Venosa
Embolia Pulmonar
COVID-19
Coronavirus Disease 2019-nCoV
Venous Thromboembolism
Pulmonary Embolism
dc.subject.keyword.none.fl_str_mv COVID-19
Coronavirus Disease 2019-nCoV
Venous Thromboembolism
Pulmonary Embolism
description La pandemia por COVID-19 ha supuesto el advenimiento de una serie de retos para los clínicos entre los que se ha descrito desde la presentación de los primeros casos la asociación entre la neumonía viral con los fenómenos embólicos. Por esta razón se describió la prevalencia de eventos embólicos en 576 pacientes con diagnóstico de COVID-19 en La Cardio en Bogotá D.C. durante el 2020 encontrando un 10,94% y 4.17% respectivamente para tromboembolismo pulmonar y trombosis venosa profunda. También se describieron las características clínicas y paraclínicas de esta cohorte encontrando similitud con aquellas reportadas en estadísticas internacionales. Este documento podrá utilizarse para el desarrollo de trabajos prospectivos que permitan la predicción y optimización del pronóstico de los pacientes.
publishDate 2023
dc.date.accessioned.none.fl_str_mv 2023-06-20T12:49:49Z
dc.date.available.none.fl_str_mv 2023-06-20T12:49:49Z
dc.date.created.none.fl_str_mv 2023-06-15
dc.type.none.fl_str_mv bachelorThesis
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.document.none.fl_str_mv Trabajo de grado
dc.type.spa.none.fl_str_mv Trabajo de grado
dc.identifier.doi.none.fl_str_mv https://doi.org/10.48713/10336_39842
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/39842
url https://doi.org/10.48713/10336_39842
https://repository.urosario.edu.co/handle/10336/39842
dc.language.iso.none.fl_str_mv spa
language spa
dc.rights.*.fl_str_mv Attribution-NonCommercial-ShareAlike 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.none.fl_str_mv Abierto (Texto Completo)
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
rights_invalid_str_mv Attribution-NonCommercial-ShareAlike 4.0 International
Abierto (Texto Completo)
http://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.extent.none.fl_str_mv 58 pp
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad del Rosario
dc.publisher.department.none.fl_str_mv Escuela de Medicina y Ciencias de la Salud
dc.publisher.program.none.fl_str_mv Especialización en Medicina Interna
publisher.none.fl_str_mv Universidad del Rosario
institution Universidad del Rosario
dc.source.bibliographicCitation.none.fl_str_mv COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. [citado 21 de abril de 2021]. Disponible en: https://coronavirus.jhu.edu/map.html
Malagon-Rojas Jeadran, Ibañez Edgar, Parra Eliana, Toloza-Perez Yesith G., Alvarez Sebastian, Mercado Marcela. Analysis of COVID-19 Mortality and Survival in Colombia A prospective Cohort Study. Infectio. 2021;25(3):176-81.
Laajaj R, De Los Rios C, Sarmiento-Barbieri I, Aristizabal D, Behrentz E, Bernal R, et al. COVID-19 spread, detection, and dynamics in Bogota, Colombia. Nat Commun. 1 de diciembre de 2021;12(1).
Lotfi M, Rezaei N. SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol [Internet]. 19 de octubre de 2020;92(10):1864-74. Disponible en: http://dx.doi.org/10.1002/jmv.26123
Gian Battista Danzi, Loffi M, Galeazzi G, Gherbesi and E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? European society of Cardiology [Internet]. 18 de agosto de 2020; Disponible en: https://www.acpjournals.org/doi/10.7326/M20-2003
Edler C, Schröder AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, et al. Correction to: Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med [Internet]. 19 de septiembre de 2020;134(5):1977-1977. Disponible en: http://link.springer.com/10.1007/s00414-020-02336-7
Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268-77.
Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med [Internet]. 4 de junio de 2020;46(6):1089-98. Disponible en: https://doi.org/10.1007/s00134-020-06062-x
Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord. 2021;9(1):23-35.
Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. Journal of Thrombosis and Haemostasis. 1 de agosto de 2020;18(8):1995-2002.
Mestre-Gómez B, Lorente-Ramos RM, Rogado J, Franco-Moreno A, Obispo B, Salazar-Chiriboga D, et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis. 2020;(0123456789):2-8.
Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 1 de julio de 2020;191:9-14.
Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care [Internet]. 16 de diciembre de 2020;24(1):353. Disponible en: https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03062-7
Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, et al. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. European Respiratory Journal [Internet]. octubre de 2020;56(4):2001811. Disponible en: http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01811-2020
Roguljić H, Arambašić J, Ninčević V, Kuna L, Šesto I, Tabl A, et al. The role of direct oral anticoagulants in the era of COVID-19: Are antiviral therapy and pharmacogenetics limiting factors? En: Croatian Medical Journal. Medicinska Naklada Zagreb; 2022. p. 287-94.
MacKman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected with SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol. 2020;(September):2033-44.
Vidali S, Morosetti D, Cossu E, Luisi MLE, Pancani S, Semeraro V, et al. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res [Internet]. 13 de abril de 2020;6(2):00260-2020. Disponible en: http://dx.doi.org/10.1183/23120541.00260-2020
Eljilany I, Elzouki AN. D-dimer, fibrinogen, and il-6 in covid-19 patients with suspected venous thromboembolism: A narrative review. Vol. 16, Vascular Health and Risk Management. Dove Medical Press Ltd; 2020. p. 455-62.
López Fontalvo J, Ballesteros Palencia SK, Coronado Pulido SY, Arias Botero JH. Incidence of venous thromboembolic events in patients hospitalized with COVID-19. Acta Colombiana de Cuidado Intensivo. 1 de junio de 2022;22:S11-8.
Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clinical and Applied Thrombosis/Hemostasis. 2020;26.
WHO. COVID-19 - China. https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON233. 2020.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 15 de febrero de 2020;395(10223):507-13.
Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 30 de abril de 2020;382(18):1708-20.
Thachil J, Cushman M, Srivastava A. A proposal for staging COVID‐19 coagulopathy. Res Pract Thromb Haemost. 2020;4(5):731-6.
Ian Leonard-Lorant, Xavier Delabranche, Francois Severac JH. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D- Dimer Levels. Radiology. 2020.
Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies. Semin Thromb Hemost. 1 de octubre de 2020;46(7):763-71.
National Institute of Health. COVID-19 Treatment Guidelines 2 [Internet]. 2022. Disponible en: https://www.covid19treatmentguidelines.nih.gov/
Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb Res. 1 de diciembre de 2020;196:67-74.
Suh YJ, Hong H, Ohana M, Bompard F, Revel MP, Valle C, et al. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. Vol. 298, Radiology. Radiological Society of North America Inc.; 2021. p. E70-80.
Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Vol. 160, Chest. Elsevier Inc.; 2021. p. 1471-80.
Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Vol. 69, Inflammation Research. Springer Science and Business Media Deutschland GmbH; 2020. p. 1181-9.
Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117(3):437-44.
Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. Journal of Thrombosis and Haemostasis [Internet]. 27 de mayo de 2020;18(5):1023-6. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14810
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of Thrombosis and Haemostasis. 1 de mayo de 2020;18(5):1094-9.
Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report. Chest. 1 de julio de 2022;162(1):213-25.
Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. Journal of Thrombosis and Haemostasis. 1 de agosto de 2020;18(8):1859-65.
Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 9 de febrero de 2021;5(3):872-88.
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 1 de abril de 2020;18(4):844-7.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 15 de febrero de 2020;395(10223):497-506.
Yousaf M, Thomas MM, Almughalles S, Hameed MA, Alharafsheh A, Varikkodan I, et al. Pulmonary embolism in COVID-19, risk factors and association with inflammatory biomarkers. Medicine (United States). 17 de febrero de 2023;102(7):E32887.
Mureșan AV, Hălmaciu I, Arbănași EM, Kaller R, Arbănași EM, Budișcă OA, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 1 de noviembre de 2022;12(11).
Cohen J. Statistical Power Analysis for the Behavioral Sciences Second Edition. 2nd edition. 1988.
Benjamini Y, Yekutieli D. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY. Vol. 29, The Annals of Statistics. 2001.
World Medical Association. World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects. Vol. 310, JAMA. American Medical Association; 2013. p. 2191-4.
Minsalud. RESOLUCIÓN NÚMERO 8430 DE 1993. 1993.
Behravesh S, Hoang P, Nanda A, Wallace A, Sheth RA, Deipolyi AR, et al. Pathogenesis of Thromboembolism and Endovascular Management. Thrombosis. 2017;2017.
Fu Z, Bai G, Song B, Wang Y, Song H, Ma M, et al. Risk factors and mortality of pulmonary embolism in COVID-19 patients: Evidence based on fifty observational studies. Medicine (United States). 11 de noviembre de 2022;101(45):E29895.
Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J, et al. Deep Vein Thrombosis in Hospitalized Patients with COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome. Circulation. 14 de julio de 2020;142(2):114-28.
Ierardi AM, Gaibazzi N, Tuttolomondo D, Fusco S, La Mura V, Peyvandi F, et al. Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables. Radiologia Medica. 1 de mayo de 2021;126(5):722-8.
Gong X, Yuan B, Yuan Y. Incidence and prognostic value of pulmonary embolism in COVID-19: A systematic review and meta-analysis. PLoS One. 1 de marzo de 2022;17(3 March).
Fraissé M, Logre E, Pajot O, Mentec H, Plantefève G, Contou D. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: A French monocenter retrospective study. Crit Care. 2020;24.
Donnellan E, Khorana AA. Cancer and Venous Thromboembolic Disease: A Review. Oncologist. 1 de febrero de 2017;22(2):199-207.
Prkacin I, Bulum T, Svagusa T, Golub A, Pikivaca T, Cavric G, et al. DEEP VENOUS THROMBOSIS AND KIDNEY DISEASE [Internet]. Vol. 36, Journal of Hypertension. 2018. Disponible en: http://journals.lww.com/jhypertension
Wang SY, Singh A, Eder MD, Vadlamani L, Lee AI, Chun HJ, et al. Association of obesity with venous thromboembolism and myocardial injury in COVID-19. Obes Res Clin Pract. 1 de septiembre de 2021;15(5):512-4.
Canadian Royal College. CLINICAL LABORATORY TESTS-REFERENCE VALUES. 2017.
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/4be23514-a303-47cc-87fd-20c2c905117e/download
https://repository.urosario.edu.co/bitstreams/660bcf96-3c34-45ba-8d6b-8572fad00ec7/download
https://repository.urosario.edu.co/bitstreams/e3a51761-d2f1-4812-bb8e-2e838efd2279/download
https://repository.urosario.edu.co/bitstreams/073bbdd1-e6f3-4290-bc08-02cbdd3362fe/download
https://repository.urosario.edu.co/bitstreams/5cdbd940-7452-4be7-9dce-7ddbe7406796/download
bitstream.checksum.fl_str_mv 9e7881edbf2ba65d886bf8b6c29b9d88
b2825df9f458e9d5d96ee8b7cd74fde6
5643bfd9bcf29d560eeec56d584edaa9
86da8b512ded2ab5b8a2b2be3413bf0c
e9409fce3c28b5a0b16481d75aab22c0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167572500709376
spelling Moreno León, Julián Mauricio318f49a5-3f49-4341-9a35-6f1d1bc6e904-1Molano González, Nicolasc35d5b86-879d-4f60-9553-b1f2c11adc22-1Gómez Sepúlveda, ValeriaSierra Breton, Juan DavidEspecialista en Medicina InternaMaestríaFull timebc6943dd-1540-4512-a57e-168246473609-174d46548-3779-49b6-9adc-19aacad6ed13-12023-06-20T12:49:49Z2023-06-20T12:49:49Z2023-06-15La pandemia por COVID-19 ha supuesto el advenimiento de una serie de retos para los clínicos entre los que se ha descrito desde la presentación de los primeros casos la asociación entre la neumonía viral con los fenómenos embólicos. Por esta razón se describió la prevalencia de eventos embólicos en 576 pacientes con diagnóstico de COVID-19 en La Cardio en Bogotá D.C. durante el 2020 encontrando un 10,94% y 4.17% respectivamente para tromboembolismo pulmonar y trombosis venosa profunda. También se describieron las características clínicas y paraclínicas de esta cohorte encontrando similitud con aquellas reportadas en estadísticas internacionales. Este documento podrá utilizarse para el desarrollo de trabajos prospectivos que permitan la predicción y optimización del pronóstico de los pacientes.The Covid-19 pandemics has presented a series of challenges for clinicians amongst which the embolic and thrombotic complications associated with viral pneumonia have been described since early 2020. Through this manuscript we describe a cohort of 576 patients admitted to La Cardio in Bogotá D. C. during 2020 finding a prevalence of 10,94% and 4,17% of pulmonary embolism and deep venous thrombosis respectively, we described their clinical and laboratory results, finding several similarities as reported in international statistics. This document will be a tool for the construction of future prospective research that allows us to predict and optimize patients’ prognosis.58 ppapplication/pdfColombiahttps://doi.org/10.48713/10336_39842https://repository.urosario.edu.co/handle/10336/39842spaUniversidad del RosarioEscuela de Medicina y Ciencias de la SaludEspecialización en Medicina InternaAttribution-NonCommercial-ShareAlike 4.0 InternationalAbierto (Texto Completo)EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.http://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. [citado 21 de abril de 2021]. Disponible en: https://coronavirus.jhu.edu/map.htmlMalagon-Rojas Jeadran, Ibañez Edgar, Parra Eliana, Toloza-Perez Yesith G., Alvarez Sebastian, Mercado Marcela. Analysis of COVID-19 Mortality and Survival in Colombia A prospective Cohort Study. Infectio. 2021;25(3):176-81.Laajaj R, De Los Rios C, Sarmiento-Barbieri I, Aristizabal D, Behrentz E, Bernal R, et al. COVID-19 spread, detection, and dynamics in Bogota, Colombia. Nat Commun. 1 de diciembre de 2021;12(1).Lotfi M, Rezaei N. SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol [Internet]. 19 de octubre de 2020;92(10):1864-74. Disponible en: http://dx.doi.org/10.1002/jmv.26123Gian Battista Danzi, Loffi M, Galeazzi G, Gherbesi and E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? European society of Cardiology [Internet]. 18 de agosto de 2020; Disponible en: https://www.acpjournals.org/doi/10.7326/M20-2003Edler C, Schröder AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, et al. Correction to: Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med [Internet]. 19 de septiembre de 2020;134(5):1977-1977. Disponible en: http://link.springer.com/10.1007/s00414-020-02336-7Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268-77.Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med [Internet]. 4 de junio de 2020;46(6):1089-98. Disponible en: https://doi.org/10.1007/s00134-020-06062-xObi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord. 2021;9(1):23-35.Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. Journal of Thrombosis and Haemostasis. 1 de agosto de 2020;18(8):1995-2002.Mestre-Gómez B, Lorente-Ramos RM, Rogado J, Franco-Moreno A, Obispo B, Salazar-Chiriboga D, et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis. 2020;(0123456789):2-8.Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 1 de julio de 2020;191:9-14.Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care [Internet]. 16 de diciembre de 2020;24(1):353. Disponible en: https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03062-7Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, et al. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. European Respiratory Journal [Internet]. octubre de 2020;56(4):2001811. Disponible en: http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01811-2020Roguljić H, Arambašić J, Ninčević V, Kuna L, Šesto I, Tabl A, et al. The role of direct oral anticoagulants in the era of COVID-19: Are antiviral therapy and pharmacogenetics limiting factors? En: Croatian Medical Journal. Medicinska Naklada Zagreb; 2022. p. 287-94.MacKman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected with SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol. 2020;(September):2033-44.Vidali S, Morosetti D, Cossu E, Luisi MLE, Pancani S, Semeraro V, et al. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res [Internet]. 13 de abril de 2020;6(2):00260-2020. Disponible en: http://dx.doi.org/10.1183/23120541.00260-2020Eljilany I, Elzouki AN. D-dimer, fibrinogen, and il-6 in covid-19 patients with suspected venous thromboembolism: A narrative review. Vol. 16, Vascular Health and Risk Management. Dove Medical Press Ltd; 2020. p. 455-62.López Fontalvo J, Ballesteros Palencia SK, Coronado Pulido SY, Arias Botero JH. Incidence of venous thromboembolic events in patients hospitalized with COVID-19. Acta Colombiana de Cuidado Intensivo. 1 de junio de 2022;22:S11-8.Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clinical and Applied Thrombosis/Hemostasis. 2020;26.WHO. COVID-19 - China. https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON233. 2020.Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 15 de febrero de 2020;395(10223):507-13.Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 30 de abril de 2020;382(18):1708-20.Thachil J, Cushman M, Srivastava A. A proposal for staging COVID‐19 coagulopathy. Res Pract Thromb Haemost. 2020;4(5):731-6.Ian Leonard-Lorant, Xavier Delabranche, Francois Severac JH. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D- Dimer Levels. Radiology. 2020.Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies. Semin Thromb Hemost. 1 de octubre de 2020;46(7):763-71.National Institute of Health. COVID-19 Treatment Guidelines 2 [Internet]. 2022. Disponible en: https://www.covid19treatmentguidelines.nih.gov/Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb Res. 1 de diciembre de 2020;196:67-74.Suh YJ, Hong H, Ohana M, Bompard F, Revel MP, Valle C, et al. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. Vol. 298, Radiology. Radiological Society of North America Inc.; 2021. p. E70-80.Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Vol. 160, Chest. Elsevier Inc.; 2021. p. 1471-80.Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Vol. 69, Inflammation Research. Springer Science and Business Media Deutschland GmbH; 2020. p. 1181-9.Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117(3):437-44.Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. Journal of Thrombosis and Haemostasis [Internet]. 27 de mayo de 2020;18(5):1023-6. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14810Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of Thrombosis and Haemostasis. 1 de mayo de 2020;18(5):1094-9.Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report. Chest. 1 de julio de 2022;162(1):213-25.Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. Journal of Thrombosis and Haemostasis. 1 de agosto de 2020;18(8):1859-65.Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 9 de febrero de 2021;5(3):872-88.Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 1 de abril de 2020;18(4):844-7.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 15 de febrero de 2020;395(10223):497-506.Yousaf M, Thomas MM, Almughalles S, Hameed MA, Alharafsheh A, Varikkodan I, et al. Pulmonary embolism in COVID-19, risk factors and association with inflammatory biomarkers. Medicine (United States). 17 de febrero de 2023;102(7):E32887.Mureșan AV, Hălmaciu I, Arbănași EM, Kaller R, Arbănași EM, Budișcă OA, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 1 de noviembre de 2022;12(11).Cohen J. Statistical Power Analysis for the Behavioral Sciences Second Edition. 2nd edition. 1988.Benjamini Y, Yekutieli D. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY. Vol. 29, The Annals of Statistics. 2001.World Medical Association. World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects. Vol. 310, JAMA. American Medical Association; 2013. p. 2191-4.Minsalud. RESOLUCIÓN NÚMERO 8430 DE 1993. 1993.Behravesh S, Hoang P, Nanda A, Wallace A, Sheth RA, Deipolyi AR, et al. Pathogenesis of Thromboembolism and Endovascular Management. Thrombosis. 2017;2017.Fu Z, Bai G, Song B, Wang Y, Song H, Ma M, et al. Risk factors and mortality of pulmonary embolism in COVID-19 patients: Evidence based on fifty observational studies. Medicine (United States). 11 de noviembre de 2022;101(45):E29895.Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J, et al. Deep Vein Thrombosis in Hospitalized Patients with COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome. Circulation. 14 de julio de 2020;142(2):114-28.Ierardi AM, Gaibazzi N, Tuttolomondo D, Fusco S, La Mura V, Peyvandi F, et al. Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables. Radiologia Medica. 1 de mayo de 2021;126(5):722-8.Gong X, Yuan B, Yuan Y. Incidence and prognostic value of pulmonary embolism in COVID-19: A systematic review and meta-analysis. PLoS One. 1 de marzo de 2022;17(3 March).Fraissé M, Logre E, Pajot O, Mentec H, Plantefève G, Contou D. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: A French monocenter retrospective study. Crit Care. 2020;24.Donnellan E, Khorana AA. Cancer and Venous Thromboembolic Disease: A Review. Oncologist. 1 de febrero de 2017;22(2):199-207.Prkacin I, Bulum T, Svagusa T, Golub A, Pikivaca T, Cavric G, et al. DEEP VENOUS THROMBOSIS AND KIDNEY DISEASE [Internet]. Vol. 36, Journal of Hypertension. 2018. Disponible en: http://journals.lww.com/jhypertensionWang SY, Singh A, Eder MD, Vadlamani L, Lee AI, Chun HJ, et al. Association of obesity with venous thromboembolism and myocardial injury in COVID-19. Obes Res Clin Pract. 1 de septiembre de 2021;15(5):512-4.Canadian Royal College. CLINICAL LABORATORY TESTS-REFERENCE VALUES. 2017.instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCOVID-19Enfermedad por Coronavirus 2019-nCoVTromboembolia VenosaEmbolia PulmonarCOVID-19Coronavirus Disease 2019-nCoVVenous ThromboembolismPulmonary EmbolismComplicaciones embólicas en pacientes infectados por SARS-COV-2. Fundación Cardioinfantil. 2020. Un estudio de prevalencia retrospectivoEmbolic complications in patients infected by SARS-COV-2. Cardioinfantil Foundation. 2020. A retrospective prevalence studybachelorThesisTrabajo de gradoTrabajo de gradohttp://purl.org/coar/resource_type/c_7a1fEscuela de Medicina y Ciencias de la SaludORIGINALComplicaciones_embolicas_en_pacientes_infectados.pdfComplicaciones_embolicas_en_pacientes_infectados.pdfapplication/pdf441144https://repository.urosario.edu.co/bitstreams/4be23514-a303-47cc-87fd-20c2c905117e/download9e7881edbf2ba65d886bf8b6c29b9d88MD51LICENSElicense.txtlicense.txttext/plain1483https://repository.urosario.edu.co/bitstreams/660bcf96-3c34-45ba-8d6b-8572fad00ec7/downloadb2825df9f458e9d5d96ee8b7cd74fde6MD52CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81160https://repository.urosario.edu.co/bitstreams/e3a51761-d2f1-4812-bb8e-2e838efd2279/download5643bfd9bcf29d560eeec56d584edaa9MD53TEXTComplicaciones_embolicas_en_pacientes_infectados.pdf.txtComplicaciones_embolicas_en_pacientes_infectados.pdf.txtExtracted texttext/plain101258https://repository.urosario.edu.co/bitstreams/073bbdd1-e6f3-4290-bc08-02cbdd3362fe/download86da8b512ded2ab5b8a2b2be3413bf0cMD54THUMBNAILComplicaciones_embolicas_en_pacientes_infectados.pdf.jpgComplicaciones_embolicas_en_pacientes_infectados.pdf.jpgGenerated Thumbnailimage/jpeg2549https://repository.urosario.edu.co/bitstreams/5cdbd940-7452-4be7-9dce-7ddbe7406796/downloade9409fce3c28b5a0b16481d75aab22c0MD5510336/39842oai:repository.urosario.edu.co:10336/398422023-10-19 09:53:25.137http://creativecommons.org/licenses/by-nc-sa/4.0/Attribution-NonCommercial-ShareAlike 4.0 Internationalhttps://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.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

Publicaciones similares